Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thomas S. Walter is active.

Publication


Featured researches published by Thomas S. Walter.


Nature Structural & Molecular Biology | 2012

A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71

Xiangxi Wang; Wei Peng; Jingshan Ren; Zhongyu Hu; Jiwei Xu; Zhiyong Lou; Xumei Li; Weidong Yin; Xinliang Shen; Claudine Porta; Thomas S. Walter; Gwyndaf Evans; Danny Axford; Robin L. Owen; David J. Rowlands; Junzhi Wang; David I. Stuart; Elizabeth E. Fry; Zihe Rao

Enterovirus 71 (EV71) is a major agent of hand, foot and mouth disease in children that can cause severe central nervous system disease and death. No vaccine or antiviral therapy is available. High-resolution structural analysis of the mature virus and natural empty particles shows that the mature virus is structurally similar to other enteroviruses. In contrast, the empty particles are markedly expanded and resemble elusive enterovirus-uncoating intermediates not previously characterized in atomic detail. Hydrophobic pockets in the EV71 capsid are collapsed in this expanded particle, providing a detailed explanation of the mechanism for receptor-binding triggered virus uncoating. These structures provide a model for enterovirus uncoating in which the VP1 GH loop acts as an adaptor-sensor for cellular receptor attachment, converting heterologous inputs to a generic uncoating mechanism, highlighting new opportunities for therapeutic intervention.


Structure | 2006

Lysine Methylation as a Routine Rescue Strategy for Protein Crystallization

Thomas S. Walter; Christoph Meier; René Assenberg; Kin Fai Au; Jingshan Ren; Anil Verma; Joanne E. Nettleship; Raymond J. Owens; David I. Stuart; Jonathan M. Grimes

Summary Crystallization remains a critical step in X-ray structure determination. Because it is not generally possible to rationally predict crystallization conditions, commercial screens have been developed which sample a wide range of crystallization space. While this approach has proved successful in many cases, a significant number of proteins fail to crystallize despite being soluble and monodispersed. It is established that chemical modification can facilitate the crystallization of otherwise intractable proteins. Here we describe a method for the reductive methylation of lysine residues which is simple, inexpensive, and efficient, and report on its application to ten proteins. We describe the effect of methylation on the physico-chemical properties of these proteins, and show that it led to diffraction-quality crystals from four proteins and structures for three that had hitherto proved refractory to crystallization. The method is suited to both low- and high-throughput laboratories.


Acta Crystallographica Section D-biological Crystallography | 2005

A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization

Thomas S. Walter; Jonathan M. Diprose; C.J. Mayo; Christian Siebold; M.G. Pickford; Lester G. Carter; Geoffrey C. Sutton; Nick S. Berrow; James Brown; Ian Berry; Guillaume Stewart-Jones; Jonathan M. Grimes; David K. Stammers; Robert M. Esnouf; E.Y. Jones; Raymond J. Owens; David I. Stuart; Karl Harlos

Crystallization trials at the Division of Structural Biology in Oxford are now almost exclusively carried out using a high‐throughput workflow implemented in the Oxford Protein Production Facility. Initial crystallization screening is based on nanolitre‐scale sitting‐drop vapour‐diffusion experiments (typically 100 nl of protein plus 100 nl of reservoir solution per droplet) which use standard crystallization screening kits and 96‐well crystallization plates. For 294 K crystallization trials the barcoded crystallization plates are entered into an automated storage system with a fully integrated imaging system. These plates are imaged in accordance with a pre‐programmed schedule and the resulting digital data for each droplet are harvested into a laboratory information‐management system (LIMS), scored by crystal recognition software and displayed for user analysis via a web‐based interface. Currently, storage for trials at 277 K is not automated and for imaging the crystallization plates are fed by hand into an imaging system from which the data enter the LIMS. The workflow includes two procedures for nanolitre‐scale optimization of crystallization conditions: (i) a protocol for variation of pH, reservoir dilution and protein:reservoir ratio and (ii) an additive screen. Experience based on 592 crystallization projects is reported.


Acta Crystallographica Section D-biological Crystallography | 2005

Towards rationalization of crystallization screening for small- to medium-sized academic laboratories: the PACT/JCSG+ strategy

Janet Newman; D. Egan; Thomas S. Walter; Ran Meged; Ian Berry; M. Ben Jelloul; Joel L. Sussman; David I. Stuart; Anastassis Perrakis

A crystallization screening process is presented that was developed for a small academic laboratory. Its underlying concept is to combine sparse-matrix screening with systematic screening in a minimum number of crystallization conditions. The sparse-matrix screen is the cherry-picked combination of conditions from the Joint Center for Structural Genomics (JCSG) extended using conditions from other screens. Its aim is to maximize the coverage of crystallization parameter space with no redundancy. The systematic screen, a pH-, anion- and cation-testing (PACT) screen, aims to decouple the components of each condition and to provide information about the protein, even in the absence of crystals, rather than cover a wide crystallization space. This screening strategy is combined with nanolitre-volume dispensing hardware and a small but practical experiment-tracking system. The screens have been tested both at the NKI and in other laboratories and it is concluded that they provide a useful minimal screening strategy.


Journal of Applied Crystallography | 2003

A procedure for setting up high-throughput nanolitre crystallization experiments. II. Crystallization results

James Brown; Thomas S. Walter; Lester G. Carter; Nicola G. A. Abrescia; A.R. Aricescu; T. D. Batuwangala; Louise E. Bird; N. Brown; P. P. Chamberlain; Simon J. Davis; E. Dubinina; J. Endicott; Janet A. Fennelly; Robert J. C. Gilbert; Maria Harkiolaki; W.C Hon; F. Kimberley; Christopher Anthony Love; Erika J. Mancini; Raquel Manso-Sancho; C.E. Nichols; R. A. Robinson; Geoffrey C. Sutton; N. Schueller; M. C. Sleeman; Guillaume Stewart-Jones; Mai Vuong; J. Welburn; Zhihong Zhang; David K. Stammers

An initial tranche of results from day-to-day use of a robotic system for setting up 100 nl-scale vapour-diffusion sitting-drop protein crystallizations has been surveyed. The database of over 50 unrelated samples represents a snapshot of projects currently at the stage of crystallization trials in Oxford research groups and as such encompasses a broad range of proteins. The results indicate that the nanolitre-scale methodology consistently identifies more crystallization conditions than traditional hand-pipetting-style methods; however, in a number of cases successful scale-up is then problematic. Crystals grown in the initial 100 nl-scale drops have in the majority of cases allowed useful characterization of x-ray diffraction, either in-house or at synchrotron beamlines. For a significant number of projects, full x-ray diffraction data sets have been collected to 3 A resolution or better (either in-house or at the synchrotron) from crystals grown at the 100 nl scale. To date, five structures have been determined by molecular replacement directly from such data and a further three from scale-up of conditions established at the nanolitre scale.


Structure | 2004

The nsp9 replicase protein of SARS-coronavirus, structure and functional insights.

Geoff Sutton; Elizabeth E. Fry; Lester G. Carter; Sarah Sainsbury; Thomas S. Walter; Joanne E. Nettleship; Nick S. Berrow; Raymond J. Owens; Robert J. C. Gilbert; Andrew D. Davidson; Stuart G. Siddell; Leo L.M. Poon; Jonathan M. Diprose; David Alderton; Martin A. Walsh; Jonathan M. Grimes; David I. Stuart

As part of a high-throughput structural analysis of SARS-coronavirus (SARS-CoV) proteins, we have solved the structure of the non-structural protein 9 (nsp9). This protein, encoded by ORF1a, has no designated function but is most likely involved with viral RNA synthesis. The protein comprises a single β-barrel with a fold previously unseen in single domain proteins. The fold superficially resembles an OB-fold with a C-terminal extension and is related to both of the two subdomains of the SARS-CoV 3C-like protease (which belongs to the serine protease superfamily). nsp9 has, presumably, evolved from a protease. The crystal structure suggests that the protein is dimeric. This is confirmed by analytical ultracentrifugation and dynamic light scattering. We show that nsp9 binds RNA and interacts with nsp8, activities that may be essential for its function(s).


Nature Communications | 2013

Picornavirus uncoating intermediate captured in atomic detail.

Jingshan Ren; Xiangxi Wang; Zhongyu Hu; Qiang Gao; Yao Sun; Xuemei Li; Claudine Porta; Thomas S. Walter; Robert J. C. Gilbert; Yuguang Zhao; Danny Axford; Mark C. Williams; Katherine E. McAuley; David J. Rowlands; Weidong Yin; Junzhi Wang; David I. Stuart; Zihe Rao; Elizabeth E. Fry

It remains largely mysterious how the genomes of non-enveloped eukaryotic viruses are transferred across a membrane into the host cell. Picornaviruses are simple models for such viruses, and initiate this uncoating process through particle expansion, which reveals channels through which internal capsid proteins and the viral genome presumably exit the particle, although this has not been clearly seen until now. Here we present the atomic structure of an uncoating intermediate for the major human picornavirus pathogen CAV16, which reveals VP1 partly extruded from the capsid, poised to embed in the host membrane. Together with previous low-resolution results, we are able to propose a detailed hypothesis for the ordered egress of the internal proteins, using two distinct sets of channels through the capsid, and suggest a structural link to the condensed RNA within the particle, which may be involved in triggering RNA release.


Acta Crystallographica Section D-biological Crystallography | 2012

In situ macromolecular crystallography using microbeams

Danny Axford; Robin L. Owen; Jun Aishima; James Foadi; Ann W. Morgan; James I. Robinson; Joanne E. Nettleship; Raymond J. Owens; Isabel Moraes; Elizabeth E. Fry; Jonathan M. Grimes; Karl Harlos; Abhay Kotecha; Jingshan Ren; Geoff Sutton; Thomas S. Walter; David I. Stuart; Gwyndaf Evans

A sample environment for mounting crystallization trays has been developed on the microfocus beamline I24 at Diamond Light Source. The technical developments and several case studies are described.


Journal of Applied Crystallography | 2003

A procedure for setting up high-throughput nanolitre crystallization experiments. I. Protocol design and validation

Thomas S. Walter; Jonathan M. Diprose; James Brown; M.G. Pickford; Raymond J. Owens; David I. Stuart; Karl Harlos

A protocol for setting up nanolitre sitting-drop vapour-diffusion experiments is reported. The procedure uses standard crystallization screening kits and 96-well crystallization plates. Reservoir solutions are transferred from 96-deep-well blocks to crystallization plates in a single step with a Robbins-Hydra pipettor. Nanolitre droplets of protein as well as reservoir solution are dispensed by a Cartesian pipetting instrument. Experiments have been carried out to characterize the performance of this instrument. Adaptations to the Cartesian, which include an anti-evaporation cover plate, are described and tested. The protocol was designed for a high-throughput facility, but can be used in any standard crystallography laboratory.


Journal of Virology | 2009

Crystal Structure of a Novel Conformational State of the Flavivirus NS3 Protein: Implications for Polyprotein Processing and Viral Replication

René Assenberg; Eloise Mastrangelo; Thomas S. Walter; Anil Verma; Mario Milani; Raymond J. Owens; David I. Stuart; Jonathan M. Grimes; Erika J. Mancini

ABSTRACT The flavivirus genome comprises a single strand of positive-sense RNA, which is translated into a polyprotein and cleaved by a combination of viral and host proteases to yield functional proteins. One of these, nonstructural protein 3 (NS3), is an enzyme with both serine protease and NTPase/helicase activities. NS3 plays a central role in the flavivirus life cycle: the NS3 N-terminal serine protease together with its essential cofactor NS2B is involved in the processing of the polyprotein, whereas the NS3 C-terminal NTPase/helicase is responsible for ATP-dependent RNA strand separation during replication. An unresolved question remains regarding why NS3 appears to encode two apparently disconnected functionalities within one protein. Here we report the 2.75-Å-resolution crystal structure of full-length Murray Valley encephalitis virus NS3 fused with the protease activation peptide of NS2B. The biochemical characterization of this construct suggests that the protease has little influence on the helicase activity and vice versa. This finding is in agreement with the structural data, revealing a single protein with two essentially segregated globular domains. Comparison of the structure with that of dengue virus type 4 NS2B-NS3 reveals a relative orientation of the two domains that is radically different between the two structures. Our analysis suggests that the relative domain-domain orientation in NS3 is highly variable and dictated by a flexible interdomain linker. The possible implications of this conformational flexibility for the function of NS3 are discussed.

Collaboration


Dive into the Thomas S. Walter's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Raymond J. Owens

Rutherford Appleton Laboratory

View shared research outputs
Top Co-Authors

Avatar

Karl Harlos

Wellcome Trust Centre for Human Genetics

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joanne E. Nettleship

Wellcome Trust Centre for Human Genetics

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Erika J. Mancini

Wellcome Trust Centre for Human Genetics

View shared research outputs
Researchain Logo
Decentralizing Knowledge